Harmony Biosciences Holdings, Inc.
$1.85B- Market cap
- $2.46B
- Debt
- +$163.66M
- Cash
- −$775.34M
Capital structure 94% equity / 6% debt · EV / Revenue 2.13x · EV / EBITDA 7.27x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
HRMY · current priceP/E 15.59x
$42.25Latest market snapshot
Implied fair value · at RBBN's multiple
$24.5142.0% below market
2.71 HRMY EPS (TTM)×9.05x RBBN P/E=$24.51
Market $42.25Implied $24.51
RBBN · current priceP/E 9.05x
$1.99Latest market snapshot
Implied fair value · at HRMY's multiple
$3.4372.4% above market
0.22 RBBN EPS (TTM)×15.59x HRMY P/E=$3.43
Market $1.99Implied $3.43